Welcome to our dedicated page for Thc Biomed Intl news (Ticker: THCBF), a resource for investors and traders seeking the latest updates and insights on Thc Biomed Intl stock.
THC Biomed Intl Ltd (THCBF) is a Canadian leader in medical cannabis research and product development, serving patients and healthcare providers through innovative solutions. This dedicated news hub provides stakeholders with essential updates on the company's scientific advancements, regulatory compliance efforts, and market positioning.
Investors and industry observers will find timely announcements about product portfolio expansions, quality control initiatives, and sustainability practices. The curated collection includes official statements on licensing milestones, research breakthroughs, and strategic partnerships within the regulated cannabis sector.
All content is sourced from verified corporate communications, ensuring reliable tracking of THC Biomed's progress in developing therapeutic cannabis products. Regular updates cover operational developments while maintaining focus on patient safety and regulatory requirements.
Bookmark this page for streamlined access to THCBF's evolving role in medical cannabis innovation. Check back frequently for objective reporting on the company's contributions to evidence-based healthcare solutions.
THC BioMed has launched Canada’s first filtered cannabis pre-rolls, Pure Cannabis Sticks, now shipped to Saskatchewan and expanding nationwide. Each stick contains 0.6 grams of cannabis and features a commercial filter. Additionally, the THC Kiss Cannabis Beverage Shot, containing 10 mg of THC, was released in Ontario. The company, founded in 2012, focuses on innovative cannabis products. Penelope Laine has been reappointed as a director, enhancing corporate governance.
THC BioMed Intl Ltd has successfully shipped its THC KISS cannabis beverage shot to the Ontario Cannabis Store, the sole legal online recreational cannabis retailer in Ontario. This product is also available in B.C. and Saskatchewan, with plans to expand distribution. THC KISS, containing 10 mg of THC per 30ml bottle, provides an alternative to smoking cannabis and has garnered positive consumer feedback. The company continues investing in product development and maintains its manufacturing internally, reinforcing its commitment to the cannabis market.
THC BioMed Intl Ltd. has announced a purchase order from the Ontario Cannabis Store for its THC Kiss Beverage Shot, marking a significant milestone for the company. The beverage shot is positioned as a viable alternative to smoking cannabis. Additionally, THC Pure Cannabis Sticks are now available on the company’s online store for medical patients at $4.20 per stick. The company also shared that board member Penelope Laine has temporarily resigned pending Health Canada's security clearance.
THC BioMed Intl Ltd. announced that its patent application for the Clone Shipper Constant Illuminated, Tamper-Resistant Plant Container has been allowed by the USPTO, marking a successful end to the application process. The company expects to receive an Issue Notification Letter shortly. Additionally, THC BioMed has submitted new products, including THC Kiss Gummies, THC Kiss Water, and THC Kiss Chocolate, for Health Canada's 60-day review period. These products are part of THC's strategy to expand its cannabis product offerings, aligning with the Cannabis 2.0 trend.
FAQ
What is the current stock price of Thc Biomed Intl (THCBF)?
What is the market cap of Thc Biomed Intl (THCBF)?
